Serina Therapeutics Stock Quote SER - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.00

Bid

Ask

Volume

21,191

5.60 Day's Range 5.9619

3.81 52 Week Range 19.93

Market Cap

53.352M

Previous Close

5.5343

Open

5.60

Last Trade

2452

Last Trade Time

Financial Volume

$ 120,380

VWAP

5.6807

Average Volume (3m)

23,692

Shares Outstanding

8,891,976

Dividend Yield

PE Ratio

-3.58

Earnings Per Share (EPS)

-1.66

Revenue

142k

Net Profit

-14.8M

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging... AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

serinatherapeutics.com

Headquarters

Dover, Delaware, USA

Founded

Serina Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker SER. The last closing price for Serina Therapeutics was $5.53. Over the last year, Serina Therapeutics shares have traded in a share price range of $ 3.81 to $ 19.93.

Serina Therapeutics currently has 8,891,976 shares outstanding. The market capitalization of Serina Therapeutics is $49.21 million. Serina Therapeutics has a price to earnings ratio (PE ratio) of -3.58.

FeaturedHertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing

Form 8-K - Current report

Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

Meet with Serina’s CEO Steven A. LedgerParkinson's disease is a progressive neurological disorder that primarily affects movementContinuous dopaminergic stimulation (CDS) has been shown to reduce...

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit

HUNTSVILLE, AL, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced a $10 million equity financing...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.21	25.260960334	4.79	6.889999	4.15	55520	5.55543408	CS
4	1.19	24.7401247401	4.81	6.889999	4.15	42503	5.3366675	CS
12	-1.27	-17.4690508941	7.27	8.14	3.81	23692	5.68002658	CS
26	-5.84	-49.3243243243	11.84	12.69	3.81	22206	6.97617222	CS
52	-5.68	-48.6301369863	11.68	19.93	3.81	18797	7.61108089	CS
156	-5.68	-48.6301369863	11.68	19.93	3.81	18797	7.61108089	CS
260	-5.68	-48.6301369863	11.68	19.93	3.81	18797	7.61108089	CS

SER - Frequently Asked Questions (FAQ)

What is the current Serina Therapeutics share price?

The current share price of Serina Therapeutics is $ 6.00

How many Serina Therapeutics shares are in issue?

Serina Therapeutics has 8,891,976 shares in issue

What is the market cap of Serina Therapeutics?

The market capitalisation of Serina Therapeutics is USD 49.21M

What is the 1 year trading range for Serina Therapeutics share price?

Serina Therapeutics has traded in the range of $ 3.81 to $ 19.93 during the past year

What is the PE ratio of Serina Therapeutics?

The price to earnings ratio of Serina Therapeutics is -3.58

What is the cash to sales ratio of Serina Therapeutics?

The cash to sales ratio of Serina Therapeutics is 372.5

What is the reporting currency for Serina Therapeutics?

Serina Therapeutics reports financial results in USD

What is the latest annual turnover for Serina Therapeutics?

The latest annual turnover of Serina Therapeutics is USD 142k

What is the latest annual profit for Serina Therapeutics?

The latest annual profit of Serina Therapeutics is USD -14.8M

What is the registered address of Serina Therapeutics?

The registered address for Serina Therapeutics is 108 LAKELAND AVE, KENT, DOVER, DELAWARE, 19901

What is the Serina Therapeutics website address?

The website address for Serina Therapeutics is serinatherapeutics.com

Which industry sector does Serina Therapeutics operate in?

Serina Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MGLDMarygold Companies Inc	$ 2.053 (48.77%)	128.45k
MINFT Limited	$ 7.25 (44.22%)	948.89k
CTMCastellum Inc	$ 0.578 (41.01%)	8.94M
KULRKULR Technology Group Inc	$ 2.885 (28.79%)	75.72M
MSTUT Rex 2X Long MSTR Daily Target ETF	$ 12.49 (22.81%)	64.96M
BATLBattalion Oil Corporation	$ 1.3499 (-44.56%)	1.63M
NVOXDefiance Daily Target 2x Long Nvo ETF	$ 11.5991 (-35.47%)	406.44k
UVIX2x Long VIX Futures ETF	$ 3.83 (-29.07%)	70.31M
TPETTrio Petroleum Corp	$ 1.10 (-25.17%)	2.79M
MSTZT Rex 2X Inverse MSTR Daily Target ETF	$ 19.235 (-23.06%)	21.21M
SPYSPDR S&P 500	$ 591.15 (0.86%)	122.49M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	$ 6.1628 (-3.25%)	114.87M
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 27.30 (3.80%)	108.08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 2.435 (7.27%)	94.23M
KULRKULR Technology Group Inc	$ 2.885 (28.79%)	75.72M